These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13954786)

  • 1. [Interaction of sodium dehydroacetate and 3-butyryl-4-hydroxycoumarin with flavins].
    HISATSUNE K
    Yakugaku Zasshi; 1963 Jan; 83():109-10. PubMed ID: 13954786
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitory action of sodium dehydroacetate and 3-butyryl-4-hydroxycoumarin on D-amino acid oxidase].
    HISATSUNE K
    Yakugaku Zasshi; 1963 Jan; 83():111-3. PubMed ID: 13954787
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE PKA VALUE OF 3-ACETYL-4-HYDROXYCOUMARIN AND DEHYDROACETIC ACID].
    ADACHI T; EJIMA A
    Eisei Shikenjo Hokoku; 1963 Oct; 81():20-3. PubMed ID: 14162024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mode of antibacterial activity of 3-acetyl-4-hydroxycoumarin and dehydroacetic acid. I].
    UKITA T; EJIMA A
    Yakugaku Zasshi; 1962 Dec; 82():1625-30. PubMed ID: 13995262
    [No Abstract]   [Full Text] [Related]  

  • 5. SYNTHESES OF SOME 4-HYDROXYCOUMARINS AND THEIR CONDENSATION PRODUCTS WITH ALDEHYDES AND CARBOXYLIC ACIDS. THE ANTICOAGULANT ACTIVITY OF SOME 4-HYDROXYCOUMARIN DERIVATIVES.
    DEZELIC M; TRKOVNIK M
    J Med Chem; 1964 May; 7():284-8. PubMed ID: 14204961
    [No Abstract]   [Full Text] [Related]  

  • 6. Rectal administration of warfarin (coumadin) sodium (sodium [3(2-acetonyl-benzyl)-4 hydroxycoumarin)]).
    FREEMAN DJ; MEYER OO
    Proc Soc Exp Biol Med; 1956 May; 92(1):52-5. PubMed ID: 13336071
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of serum cholinesterase by certain derivatives of 4-hydroxycoumarin].
    GROSSMANN V; HAIS IM; KASALICKY B
    Cas Lek Cesk; 1950 Apr; 89(17):487-8. PubMed ID: 15414533
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and characterization of some new 4-hydroxy-coumarin derivatives.
    Al-Majedy YK; Kadhum AA; Al-Amiery AA; Mohamad AB
    Molecules; 2014 Aug; 19(8):11791-9. PubMed ID: 25105917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of 4-hydroxycoumarin anticoagulant no. 63.
    ROTTER R; MEYER OO
    J Lab Clin Med; 1950 Dec; 36(6):981-2. PubMed ID: 14795070
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of 4-hydroxycoumarin anticoagulant No. 63.
    ROTTER R; MEYER OO
    AMA Arch Intern Med; 1951 Sep; 88(3):296-309. PubMed ID: 14856458
    [No Abstract]   [Full Text] [Related]  

  • 11. [CONDENSATION OF THE AL-FORM OF SUGARS WITH 4-HYDROXYCOUMARIN].
    ZHDANOV IuA; BOGDANOVA GV; ZOLOTUKHINA VG
    Dokl Akad Nauk SSSR; 1964 Aug; 157():917-8. PubMed ID: 14265029
    [No Abstract]   [Full Text] [Related]  

  • 12. The anticoagulant action of some derivatives of 3,3'-(arylidene)-bis-4-hydroxycoumarin.
    GUMINSKA M; ECKSTEIN M
    J Med Pharm Chem; 1961 May; 3():583-95. PubMed ID: 13902930
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of a new anticoagulant with a Dicoumarol-like structure: 3,3'-methylthiopropylidene-bis-(4-hydroxycoumarin) (M.T.H.)].
    BERGOGNE C; KAUFMANN H; CORABOEUF E; BRETON
    Sem Hop Ther Paris; 1962 Apr; 38():342-6. PubMed ID: 13867778
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of 4 hydroxycoumarin anticoagulant No. 63 upon the prothrombin time in dogs and human beings.
    BATTLE WD; CAPPS RT
    J Lab Clin Med; 1950 Jan; 35(1):8-15. PubMed ID: 15400618
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of prostaglandin biosynthesis by coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin.
    Lee RE; Bykadi G; Ritschel WA
    Arzneimittelforschung; 1981; 31(4):640-2. PubMed ID: 7195710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activity of compounds possessing a tricarbonylmethane group. X. Observations on the acetylation of 4-hydroxycoumarin and synthesis of 3-(alpha-aminophenylacetyl)-4-hydroxycoumarins].
    ARAKAWA K
    Pharm Bull; 1953 Dec; 1(4):331-4. PubMed ID: 13166555
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of sodium N-lauroyl sarcosinate and of sodium dehydroacetate on the enzymes of the gastrointestinal tract.
    BAUER CW; LA SALA EF
    J Am Pharm Assoc Am Pharm Assoc; 1956 Oct; 45(10):675-8. PubMed ID: 13366808
    [No Abstract]   [Full Text] [Related]  

  • 18. [CHANGES IN THE HAMOLSKY TEST IN RATS AFTER ADMINISTRATION OF ANTICOAGULANT SUBSTANCES (HEPARIN AND 4-HYDROXYCOUMARIN)].
    CABASSA N; SCIASCIA R
    Radiobiol Radioter Fis Med; 1964; 19():3-9. PubMed ID: 14169297
    [No Abstract]   [Full Text] [Related]  

  • 19. [The possible tautomeric forms of 4-hydroxycoumarin].
    KLOSA J
    Arch Pharm Ber Dtsch Pharm Ges; 1953; 23(1):37-43. PubMed ID: 13066059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Derivative of 4-hydroxycoumarin as a new anticoagulant].
    KLOSA J
    Pharmazie; 1954 Aug; 9(8):622. PubMed ID: 13224346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.